PGEN: Precigen, Inc. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Geopolitik keskinliklar xalqaro klinik sinovlar tarmoqlariga putur yetkazmoqda va saraton terapiyalaridan foydalanish imkoniyatlarini cheklamoqda. P/E va o'sish nisbati grafigi ushbu tendentsiyani vizuallashtiradi, bunda 0.00 ushbu parametrning miqdorini aks ettiradi. Precigen, Inc. (PGEN) AQShda joylashgan o'zining bio-ishlab chiqarish korxonasi orqali ishlab chiqarish barqarorligini ta'minlaydi, biroq tijorat mahsulotlarining yo'qligi kompaniyani tashqi moliyalashtirish va grantlarga bog'liq holda qoldiradi.
Precigen, Inc. (PGEN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Precigen, Inc.|PGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi precigen.com|PGEN - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Intrexon|PGEN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Precigen|Oraliq qoplash koeffitsiyenti precigen.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PGEN - Sof foyda|Kutilayotgan sof foyda Precigen, Inc.|PGEN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Precigen Corp|PGEN - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Intrexon|PGEN - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun sof foyda Precigen|PGEN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi precigen.com|PGEN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Precigen, Inc.
Kompaniyaning umumiy tahlili:PGEN - Precigen Inc
Ushbu ko'rsatkich joriy bozor P/E koeffitsientini kutilayotgan foyda o'sishi bilan solishtiradi va qiymatlar birdan pastga tushganda past baholangan aktivlarni aniqlaydi. PEG koeffitsientini tahlil qilish orqali investor Precigen, Inc. (PGEN) kompaniyasining o'sish potentsialini baholashi mumkin, bunda mualliflikka tegishli UltraCAR-T platformasining yuqori texnologik qiymati FDA ning qat'iy klinik sinovlaridan o'tish risklari bilan muvozanatlashishi kerak.
Precigen, Inc. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|tourmalinebio.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PHAR (Pharming Group) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Nektar Therapeutics Inc NKTR|PEG multiplikatori UPB|Narx-foyda va o‘sish multiplikatori Zenas Corp ZBIO|PEG multiplikatori IMNM (Immunome, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati gossamerbio.com (GOSS)|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Septerna, Inc. (SEPN)|PVLA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Savara Pharma (SVRA)|Narxning foydaga va o‘sish sur’atiga nisbati Rigel Pharmaceuticals|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ANAB (anaptysbio.com)|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aerovate Therapeutics, Inc. (JBIO)|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|KYTX (kyvernatx.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TLSA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Cabaletta Bio Inc.|Narx-foyda va o‘sish multiplikatori VTYX|Theratechnologies, Inc (THTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|ELDN: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori AGEN (Agenus Inc.)|Narxning sof foyda o‘sishiga nisbati Climb Bio Inc.|Zura Bio Limited - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda aTyr Pharmaceuticals|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti IMA|Narxning foydaga va o‘sish sur’atiga nisbati Shattuck Labs Inc|Equillium Bio - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CNTB|IMUX (immunic-therapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATRA (Atara Bio)|PEG multiplikatori InflaRx NV IFRX|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - PEG multiplikatori|PEG multiplikatori kezarlifesciences.com|Narx-foyda va o‘sish multiplikatori SABS (SAB Biotherapeutics, Inc.)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Q32 Bio Inc (QTTB)|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|edesabiotech.com (EDSA) - Narx-foyda va o‘sish multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|Narx-foyda va o‘sish multiplikatori XTLB|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|aptevotherapeutics.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|Aditxt Inc. (ADTX) - O‘sish sur’atiga tuzatilgan narx-foyda|GRI - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Scinai Immunotherapeutics Ltd SCNI|PEG multiplikatori CALI|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|PEG multiplikatori ALLK (Allakos)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati iTeos Therapeutics Inc (ITOS)|OCEA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda TC BioPharm Ltd (TCBP)|Narxning foydaga va o‘sish sur’atiga nisbati Third Harmonic Bio
